Search Results - "Leone, J.P."

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
  2. 2

    Phase I dose-escalation trial of tucatinib in combination with trastuzumab in patients with HER2-positive breast cancer brain metastases by Metzger Filho, O., Leone, J.P., Li, T., Tan-Wasielewski, Z., Trippa, L., Barry, W.T., Younger, J., Lawler, E., Walker, L., Freedman, R.A., Tolaney, S.M., Krop, I., Winer, E.P., Lin, N.U.

    Published in Annals of oncology (01-09-2020)
    “…Brain metastases are frequent in HER2-positive breast cancer. ONT-380 (tucatinib) is a potent selective inhibitor of HER2 with intracranial activity in…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7